Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Antioxidant vitamin supplementation for preventing and slowing the progression of age-related cataract.

Mathew MC, Ervin AM, Tao J, Davis RM.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD004567. doi: 10.1002/14651858.CD004567.pub2. Review.

2.

Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.

Evans JR, Lawrenson JG.

Cochrane Database Syst Rev. 2012 Jun 13;(6):CD000253. doi: 10.1002/14651858.CD000253.pub3. Review.

PMID:
22696317
3.

Canadian expert consensus: optimal treatment of neovascular age-related macular degeneration.

Cruess AF, Berger A, Colleaux K, Greve M, Harvey P, Kertes PJ, Sheidow T, Tourville E, Williams G, Wong D.

Can J Ophthalmol. 2012 Jun;47(3):227-35. doi: 10.1016/j.jcjo.2012.03.007. Epub 2012 May 12. Erratum in: Can J Ophthalmol. 2012 Oct;47(5):460.

PMID:
22687297
4.

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results.

Comparison of Age-related Macular Degeneration Treatments Trials (CATT) Research Group, Martin DF, Maguire MG, Fine SL, Ying GS, Jaffe GJ, Grunwald JE, Toth C, Redford M, Ferris FL 3rd.

Ophthalmology. 2012 Jul;119(7):1388-98. doi: 10.1016/j.ophtha.2012.03.053. Epub 2012 May 1.

5.

Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C.

Cochrane Database Syst Rev. 2012 Mar 14;(3):CD007176. doi: 10.1002/14651858.CD007176.pub2. Review.

PMID:
22419320
6.

Genetics of age-related macular degeneration.

Ting AY, Lee TK, MacDonald IM.

Curr Opin Ophthalmol. 2009 Sep;20(5):369-76. doi: 10.1097/ICU.0b013e32832f8016. Review.

PMID:
19587596
7.

Age-related macular degeneration.

Jager RD, Mieler WF, Miller JW.

N Engl J Med. 2008 Jun 12;358(24):2606-17. doi: 10.1056/NEJMra0801537. Review. No abstract available. Erratum in: N Engl J Med. 2008 Oct 16;359(16): 1736.

PMID:
18550876
8.
9.

Risk factors for the incidence of Advanced Age-Related Macular Degeneration in the Age-Related Eye Disease Study (AREDS) AREDS report no. 19.

Clemons TE, Milton RC, Klein R, Seddon JM, Ferris FL 3rd; Age-Related Eye Disease Study Research Group.

Ophthalmology. 2005 Apr;112(4):533-9.

10.

Causes and prevalence of visual impairment among adults in the United States.

Congdon N, O'Colmain B, Klaver CC, Klein R, Muñoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P; Eye Diseases Prevalence Research Group.

Arch Ophthalmol. 2004 Apr;122(4):477-85.

PMID:
15078664
11.

A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8.

Age-Related Eye Disease Study Research Group.

Arch Ophthalmol. 2001 Oct;119(10):1417-36. Erratum in: Arch Ophthalmol. 2008 Sep;126(9):1251.

Items per page

Supplemental Content

Write to the Help Desk